EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS023-06818 
Organism
Homo sapiens 
Tissue/cell
CD8+ 
Coordinate
chr13:46977070-46979830 
TF binding sites/motifs
Number: 22             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr13:46979012-46979030GGAAGTGAGAAAGGAAGA+6.09
EWSR1-FLI1MA0149.1chr13:46978959-46978977GCAAGGCAGGAAGGGAGG+6.53
EWSR1-FLI1MA0149.1chr13:46978955-46978973AGAAGCAAGGCAGGAAGG+6.92
EWSR1-FLI1MA0149.1chr13:46978971-46978989GGGAGGAAGGGAGGGAGG+6.92
EWSR1-FLI1MA0149.1chr13:46978951-46978969GGAAAGAAGCAAGGCAGG+7.36
EWSR1-FLI1MA0149.1chr13:46978975-46978993GGAAGGGAGGGAGGAAAG+7.64
EWSR1-FLI1MA0149.1chr13:46978967-46978985GGAAGGGAGGAAGGGAGG+8.06
EWSR1-FLI1MA0149.1chr13:46978963-46978981GGCAGGAAGGGAGGAAGG+8.08
EWSR1-FLI1MA0149.1chr13:46979041-46979059GGAAGGAAGGAAGGGAGC+8.31
EWSR1-FLI1MA0149.1chr13:46979033-46979051GGGAGGGAGGAAGGAAGG+8.32
EWSR1-FLI1MA0149.1chr13:46979037-46979055GGGAGGAAGGAAGGAAGG+9.47
IRF1MA0050.2chr13:46977202-46977223CTTCAGTTTCTGTTTTCTCTT+6.04
Pou2f3MA0627.1chr13:46979750-46979766GCTCATTAGCATAAGA-6.15
ZNF263MA0528.1chr13:46979024-46979045GGAAGAGGGGGGAGGGAGGAA+6.22
ZNF263MA0528.1chr13:46979038-46979059GGAGGAAGGAAGGAAGGGAGC+6.23
ZNF263MA0528.1chr13:46978977-46978998AAGGGAGGGAGGAAAGGGAGG+6.45
ZNF263MA0528.1chr13:46979021-46979042AAAGGAAGAGGGGGGAGGGAG+6.4
ZNF263MA0528.1chr13:46979035-46979056GAGGGAGGAAGGAAGGAAGGG+6.99
ZNF263MA0528.1chr13:46978981-46979002GAGGGAGGAAAGGGAGGGAAG+7.25
ZNF263MA0528.1chr13:46979031-46979052GGGGGAGGGAGGAAGGAAGGA+7.34
ZNF263MA0528.1chr13:46978969-46978990AAGGGAGGAAGGGAGGGAGGA+7.37
ZNF263MA0528.1chr13:46978972-46978993GGAGGAAGGGAGGGAGGAAAG+7.56
Number of super-enhancer constituents: 4             
IDCoordinateTissue/cell
SE_11021chr13:46973937-46979681CD20
SE_39700chr13:46978195-46979246Jurkat
SE_58380chr13:46942494-46980019Ly1
SE_61451chr13:46941600-46980495Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr134697811846978313
Number: 1             
IDChromosomeStartEnd
GH13I046403chr134697773646980014
Enhancer Sequence
AAAATCAATT GTTTAATAGT TAAACAAAAA CCCTGAGATA TCCTCATGAT AACCTTGTTT 60
GGAATTAAGA CAGAATCAAG AAGTCAAGCC ACTGTAACTT GAAGCATTCC TCTTCAAGAA 120
CCTCTCCATC TTCTTCAGTT TCTGTTTTCT CTTTTTCCTC CTGTCCATCA CCTGAATCGC 180
CCTTTAAATT TGCAAGTCCT GAGAGTGGTG CCTCACCAAG GGCTCTCTGT GGGCCCTGCG 240
TCTTTGCTGA GCTCACCCTA GTTTGAGCAG TGGTCAGGCA ATAGTCAGTT TCTCCTGGCA 300
GAGTCACCAT TCCCTTATCT GTGCTCTTCT AAGCCTCTGG AAATTAGAAA CTTCCCCTAA 360
GCACTTTCTT TCCAGGAAGG AGACTCAAAA TATTCCTTTT CCTGTGCCCC ACACCTGCGT 420
TCTCAGCACT CATACTTCTC CAGGTTATAT TCCTGTTAGT TGTGTTAAGG TCTTTTTCTG 480
TCCTTTAGTG ATTGAAGCAG ATGCATTCAA TCTGAAATCT GAAAATCTTA TATCAAATCT 540
TGGCTCCACT TTGAGTAATG TATTAAAGTC AGATGAGCTT TCCTTCTCTC TTCTGTCAAT 600
AGAATTACCT TCCTATGATA AGACTTGGTG GGGGAATTAA GGAGGTAAAG TAATTTACTT 660
AAACATACTT CAACAACCAA CAATGATTAT CATGCAACCA ATGCAACCAA AACTCTTTCT 720
TTGCACTTTT TTCTTTTCTT TTTTCTTTTT TTTTGAAACA GAGTCTCACT CTGTTGCCCA 780
GGCTGGAGTG CAGCGGCGCA ATCTCAGCTC ACTGCAACCT CTGCCCCTGA GTTCAAGCAA 840
TTCTGCCGCC TCAGCCTCCC AAGTAGCTGG TGCCTGCCAC CACACCCAGC TAATTTTTGT 900
ATTTTTCGTA GAGATGGGGT TTCATCATGT TGGCCAGGCT GGTCTTGAAC TCCTGACCGC 960
AGGTGATCTG CCTGCCTAGG CCTCCCAAAG TGCTGGGTTA CAGGCGTGAG CCACCGTGCC 1020
CAGCCTCTTT GCACTACTTG AGGACCATCA AAGGCAATCG CACTCATGAC TCTCAGTCTT 1080
ACTTTATTGC ATTCCATTTC CCCTCCCCTC AGCTTCATTT ACACCCAGAG CCTCCTCCCA 1140
AGTGTCTCTC ACTCTCCAAG TGCCACTTCT TACAGGAAGT TACTCAACAC ACAGTAGCTA 1200
GTGTTTGTGT CTATATTTTC GACAGCAACT GACACAGAGC CTACCACATA ATGAGAGCTC 1260
CACAAACATT TGTGAAATTG AATGGAGTTT TATCAGAATA CAGAGATCTT ACTACAAAAA 1320
AACTAGAGTA AATAACTTTT TCTTCTAAAA AAAAAGTTCA ACCTCAGTTA CCTCTCTCAT 1380
TGCTAACCTC ATTCCCTCCC CCTTGTAGCC ACCATCACCA CCCCAGGGCA GAAAGGGCAT 1440
CTGGAACATG ATGTGGCATT TCCTTCAGCA TCCCTACCCC CACCATTAGC TTAATTTGTT 1500
AGGACAGTGA CCAGGGAGTG ACTGCAATCA AAGGGAGGGT GCTGTGTGCT TCTCTCCAGC 1560
TCTGAAGTGC GGCTAACTCT CCTTAGGATG TAATCAGAGA TTCTTCTTCA GAAGTCCTTG 1620
GCGTACTTTT CCTAGCTCAC CACAACTATT TCTTCAGTTC ACGTCCAAGA GGAATGGGAT 1680
CATGTTGTAT AAATTAAACA TTTTGCTTCT CCTCTATCAA CCCAGATCCA TATTTATATC 1740
CACTATTGCT GTTCTGATGA TGGAAGATTC CCATCATTGC TTCTTTGGTT CACACTCCAG 1800
CAGCAGAGTC ATGCGTCTCA CAGTCTCTAA GGCCACTATA GTAGTTACTG GATTAACAGT 1860
AACATCAAAA AAGAAGGAAA AGGAAAGAAG CAAGGCAGGA AGGGAGGAAG GGAGGGAGGA 1920
AAGGGAGGGA AGGAGTGAAA GAGGAAGTGA GAAAGGAAGA GGGGGGAGGG AGGAAGGAAG 1980
GAAGGGAGCT TATTCAGCTT ATTGTCAAGT TCAAGAGAGG CTCATATTTC TTTATATATA 2040
GTAGTAATAT TTTCAGAACC AAAAATGAGG ATATAGCCTG ATGAATGACA TTTTCTGATT 2100
TTTAATTATA CAATTCATAA AGTAATTAAA ATTTTGCTAA ATTTACTTGA AAACATGTAT 2160
TAATTAGCCT TTATTGGAAA GAAAGCAATT TAATGTAATC ATGTTTATCT GAAAAATTCA 2220
TGAGATTAGA TTATTTTGCT TATGTGGATT GGTTGAAGTG GCAATGGACA TAATTCTTAA 2280
AGCAGCACAA TTTTCCCTAA TCAGTTTCTA TTCCTGTGAC TCTATCTTAT GCTTTCTTAT 2340
GAAATTGAAA TGGCATCGAA TCTACTTAAA CACATTTCAA GAACCAACCA TATTAATGCT 2400
GCAGTGAGCC ATGATTGTGT CACTGTACTT CAGCTTCAGT GACAGAACAA GGTCCTGTCT 2460
CAAAAAAAAA AAAAAAAAAA AAACAGCAAT AATTATAATG CAACCAAAAC TCTTTCTTTG 2520
CATTTTTAAA GGATCATCAG AGGTGATCAT AACTCTCTAC CCTACTTCAC CACATTTAGT 2580
TGAAGTAGGA GACCACTGGC AGGACTTATT TCTTGGTCCC CATGGTAAAG TAAAGAAACT 2640
GGCAGGAACC AGCAGATGGC CAGAAAAGTG ATCCCTAGCT GCTCATTAGC ATAAGACACT 2700
CCTACCAGCA CCATGACAGT TCACAAATGC CATGACAACC ACCCAGAAGT TACTGCCCCT 2760